New molecular insights into cancer stem cells highlight their potential as therapeutic targetsColon cancer is often driven by cancer stem cells, which resist treatment and lead to relapse. In a recent study, researchers from Japan revealed how transcription factors CDX1 and CDX2 suppress cancer...